Oxford Immunotec Ltd:企業の製品パイプライン分析

◆英語タイトル:Oxford Immunotec Ltd - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME6331PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥172,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥258,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oxford Immunotec Ltd (Oxford Immunotec) a subsidiary of Oxford Immunotec Global Plc is a medical device company that offers proprietary tests for immune-regulated conditions. The company offers in vitro diagnostic, T-SPOT CMV Test, C6 Lyme ELISA Test, T-Cell Xtend Reagent. It offers T-SPOT.TB test that diagnoses both latent TB infection and active disease by measuring T cells that have been activated by Mycobacterium tuberculosis antigens. Oxford Immunotec’s T-SPOT solution offers diagnosing disease by measuring immune response to an infection. The company offers laboratories services such as oxford diagnostics. It operates in the US, the UK, Japan, South Korea and China. Oxford Immunotec is headquartered in Abingdon, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Oxford Immunotec Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Oxford Immunotec Ltd Company Overview
Oxford Immunotec Ltd Company Snapshot
Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview
Oxford Immunotec Ltd – Pipeline Analysis Overview
Oxford Immunotec Ltd – Key Facts
Oxford Immunotec Ltd – Major Products and Services
Oxford Immunotec Ltd Pipeline Products by Development Stage
Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status
Oxford Immunotec Ltd Pipeline Products Overview
B Cell ELISPOT Assay
B Cell ELISPOT Assay Product Overview
ELISPOT Tumor Assay
ELISPOT Tumor Assay Product Overview
I-O Monitoring Test
I-O Monitoring Test Product Overview
Metabovis Assay – Homocysteine
Metabovis Assay – Homocysteine Product Overview
Risk Stratification System – Kidney Transplantation
Risk Stratification System – Kidney Transplantation Product Overview
SpiroFind
SpiroFind Product Overview
Stratokine
Stratokine Product Overview
T-Cell Select
T-Cell Select Product Overview
T-SPOT Discovery SARS-CoV-2 Test Kit
T-SPOT Discovery SARS-CoV-2 Test Kit Product Overview
T-SPOT Discovery SARS-CoV-2 Test Kit Clinical Trial
T-SPOT.ICA
T-SPOT.ICA Product Overview
UREA And T-SPOT Based Diagnostic Assay – Immunological Disease
UREA And T-SPOT Based Diagnostic Assay – Immunological Disease Product Overview
UREA And T-SPOT Based Diagnostic Assay – Infectious Disease
UREA And T-SPOT Based Diagnostic Assay – Infectious Disease Product Overview
Oxford Immunotec Ltd – Key Competitors
Oxford Immunotec Ltd – Key Employees
Oxford Immunotec Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Oxford Immunotec Ltd, Recent Developments
Aug 04, 2020: Oxford Immunotec reports second quarter 2020 financial results
Feb 20, 2020: Oxford Immunotec announces new data on the utility of T-SPOT.CMV in kidney and stem cell transplant
Jan 23, 2020: Oxford Immunotec announces donation in support of Coronavirus testing efforts to help differentiate Tuberculosis from the new China virus
Nov 05, 2019: Oxford Immunotec reports third quarter 2019 financial results
Aug 06, 2019: Oxford Immunotec reports second quarter 2019 financial results
Jun 24, 2019: Oxford Immunotec appoints Patrick J. Balthrop, Sr. as Chairman
May 17, 2019: Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel
May 09, 2019: Oxford Immunotec reports first quarter 2019 financial results
Mar 28, 2019: Oxford Immunotec announces new initiative to bring the benefit of modern tuberculosis testing to the Russian Federation
Mar 21, 2019: Oxford Immunotec announces Chief Financial Officer transition
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Oxford Immunotec Ltd Pipeline Products and Ongoing Clinical Trials Overview
Oxford Immunotec Ltd Pipeline Products by Equipment Type
Oxford Immunotec Ltd Pipeline Products by Indication
Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status
Oxford Immunotec Ltd, Key Facts
Oxford Immunotec Ltd, Major Products and Services
Oxford Immunotec Ltd Number of Pipeline Products by Development Stage
Oxford Immunotec Ltd Pipeline Products Summary by Development Stage
Oxford Immunotec Ltd Ongoing Clinical Trials by Trial Status
Oxford Immunotec Ltd Ongoing Clinical Trials Summary
B Cell ELISPOT Assay - Product Status
B Cell ELISPOT Assay - Product Description
ELISPOT Tumor Assay - Product Status
ELISPOT Tumor Assay - Product Description
I-O Monitoring Test - Product Status
I-O Monitoring Test - Product Description
Metabovis Assay - Homocysteine - Product Status
Metabovis Assay - Homocysteine - Product Description
Risk Stratification System - Kidney Transplantation - Product Status
Risk Stratification System - Kidney Transplantation - Product Description
SpiroFind - Product Status
SpiroFind - Product Description
Stratokine - Product Status
Stratokine - Product Description
T-Cell Select - Product Status
T-Cell Select - Product Description
T-SPOT Discovery SARS-CoV-2 Test Kit - Product Status
T-SPOT Discovery SARS-CoV-2 Test Kit - Product Description
T-SPOT Discovery SARS-CoV-2 Test Kit - A Phase I/II Randomized, Two Parts, Dose-finding Study to Evaluate the Safety, Tolerability and Immunogenicity of an Inactivated, Adjuvanted Sars-cov-2 Virus Vaccine Candidate (Vla2001), Against Covid-19 in Healthy Subjects
T-SPOT.ICA - Product Status
T-SPOT.ICA - Product Description
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease - Product Status
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease - Product Description
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease - Product Status
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease - Product Description
Oxford Immunotec Ltd, Key Employees
Oxford Immunotec Ltd, Subsidiaries
Glossary

★海外企業調査レポート[Oxford Immunotec Ltd:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • American Gene Technologies International Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary American Gene Technologies International Inc (AGT) is a drug development company that tests and commercializes gene-based drugs. The company develops therapies for the treatment of cancer, neurological disorders, AIDS, infectious diseases, Parkinson’s diseases, diabetes, familial dysautonomi …
  • Societe Tunisienne de l’Electricite et du Gaz:電力:M&Aディール及び事業提携情報
    Summary Societe Tunisienne de l'Electricite et du Gaz (STEG) is a non-administrative Tunisian public company that produces liquefied petroleum gas (LPG) and electricity, transports, and distributes electricity and natural gas. As a public company, its mandate includes developing the natural gas netw …
  • Total SA (FP):石油・ガス:M&Aディール及び事業提携情報
    Summary Total SA (Total) is an integrated global energy company that discovers, produces, refines and markets oil and gas, and also manufactures petrochemicals. It carries out drilling, oil and gas production, processing, transportation, refining and petrochemical production, storage and distributio …
  • Mahindra & Mahindra Limited:企業の戦略・SWOT・財務情報
    Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Cabot Corp (CBT):企業の財務・戦略的SWOT分析
    Cabot Corp (CBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Guardian Industries Corp:企業の戦略的SWOT分析
    Guardian Industries Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Omega Diagnostics Group Plc (ODX):企業の財務・戦略的SWOT分析
    Summary Omega Diagnostics Group Plc (Omega) is a biotechnology company that provides in-vitro diagnostic products. The company offers products in the areas of allergy, food intolerance, autoimmune disease and infectious disease, among others. It also provides food intolerance and autoimmune tests fo …
  • Actuant Corporation:企業の戦略・SWOT・財務情報
    Actuant Corporation - Strategy, SWOT and Corporate Finance Report Summary Actuant Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • STRATEC Biomedical AG (SBS):企業の財務・戦略的SWOT分析
    Summary STRATEC Biomedical AG (STRATEC), formerly Stratec Biomedical Systems AG is a medical equipment provider that develops and manufactures automated systems for clinical diagnostics. The company provides instrumentation, data management, molecular solutions, and others. It offers data management …
  • Hospira Inc:医療機器:M&Aディール及び事業提携情報
    Summary Hospira Inc (Hospira), a subsidiary of Pfizer Inc, is a medical device company that offers injectable drugs and infusion technologies. The company offers products such as generic acute-care and oncology injectables, biosimilars, infusion systems, IV sets, IV safety devices, biosimilars, diff …
  • Ikon Science Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Ikon Science Ltd (Ikon Science) is an oil and gas company that offers software technology and consulting services. The company provides RockDoc software. Its RokDoc software offers access to rock physics forward or reverse modeling, seismic inversion, log data synthesis, inversion feasibilit …
  • Investor AB (INVE B):企業の財務・戦略的SWOT分析
    Investor AB (INVE B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • H.B. Fuller Co (FUL):企業の財務・戦略的SWOT分析
    H.B. Fuller Co (FUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ovensa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ovensa Inc (Ovensa) is a preclinical stage company that develops nanotherapeutics. The company uses its proprietary Triozan Nanomedicine delivery platform that has mucosal and brain-barrier crossing properties used in treatment of oncology and neurodegenerative diseases. Its Triozan helps in …
  • Edwards Lifesciences Corporation:企業のM&A・事業提携・投資動向
    Edwards Lifesciences Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Edwards Lifesciences Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Hydro One Ltd (H):企業の財務・戦略的SWOT分析
    Hydro One Ltd (H) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Misr Hotels Co:企業の戦略・SWOT・財務分析
    Misr Hotels Co - Strategy, SWOT and Corporate Finance Report Summary Misr Hotels Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • RBC Bearings Inc (ROLL):企業の財務・戦略的SWOT分析
    Summary RBC Bearings Inc (RBC Bearings) is an industrial equipment company that manufactures and markets engineered precision bearings and products. The company offers products through industrial and aerospace division. Its industrial products include ball bearings, cam followers, collets and toolho …
  • Galderma SA:医療機器:M&Aディール及び事業提携情報
    Summary Galderma SA (Galderma), a subsidiary of Nestle SA, is a pharmaceutical company that develops and markets drugs, medical dermatology solutions and therapeutic skin care products for the treatment of hair, nail, and skin diseases. Galderma offers products for the treatment of skin conditions s …
  • Australia and New Zealand Banking Group Ltd:戦略・SWOT・企業財務分析
    Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆